Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Nicole Artz, MD, Assistant Professor of Medicine at the University of Chicago Hospital, discusses the increasing role of the internist in the management of patients with sickle cell…
Josh Levitsky, MD, Assistant Professor, Division of Hepatology from Northwestern University, provides an overview of the epidemiology and clinical progression of Hepatitis B. References and Resources Gish RG,…
Stephen Brunton, MD, Director of Faculty Development, Cabarrus Family Medicine, Charlotte, North Carolina, discusses the most recent U.S. Preventive Services Task Force (USPSTF) recommendation and supporting scientific evidence…
General Surgeon, Les Edrich, MD provides some insight toward negotiating the delicate balance of providing information, treatment options, and an opinion regarding the best course of treatment while…